UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies

The oncologist (Dayton, Ohio), 2009-03, Vol.14 (3), p.253-263

2009

Volltextzugriff (PDF)

Phase III Trial of Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care in Previously Treated Patients With Advanced Malignant Pleural Mesothelioma

Journal of clinical oncology, 2008-04, Vol.26 (10), p.1698-1704

2008

Volltextzugriff (PDF)

Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial

Clinical cancer research, 2005-01, Vol.11 (2), p.690-696

2005

Volltextzugriff (PDF)

Interaction of pemetrexed disodium (ALIMTA, multitargeted antifolate) and irradiation in vitro

International journal of radiation oncology, biology, physics, 2002-04, Vol.52 (5), p.1381-1388

2002

Volltextzugriff (PDF)

Antifolate Pseudo-resistance Due to Elevated Levels of Thymidine and Hypoxanthine in a Commercial Serum Preparation

Anticancer research, 2007-03, Vol.27 (2), p.769-773

2007

Volltextzugriff (PDF)

Radiosensitizing potential of gemcitabine (2′,2′-difluoro-2′-deoxycytidine) within the cell cycle in vitro

International journal of radiation oncology, biology, physics, 1998-07, Vol.41 (4), p.875-882

1998

Volltextzugriff (PDF)

Pemetrexed Plus Cisplatin or Pemetrexed Plus Carboplatin for Chemonaïve Patients with Malignant Pleural Mesothelioma: Results of the International Expanded Access Program

Journal of thoracic oncology, 2008-07, Vol.3 (7), p.756-763

2008

Volltextzugriff (PDF)

Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled Trial of Remimazolam: A New Ultra Short Acting Benzodiazepine for Bronchoscopy

Chest, 2017-10, Vol.152 (4), p.A739-A739

2017

Volltextzugriff (PDF)

Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B 12 as Front-Line Therapy in Malignant Pleural Mesothelioma

Journal of clinical oncology, 2003-04, Vol.21 (8), p.1556-1561

2003

Volltextzugriff (PDF)

Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B12 as Front-Line Therapy in Malignant Pleural Mesothelioma

Journal of clinical oncology, 2003-04, Vol.21 (8), p.1556-1561

2003

Volltextzugriff (PDF)

Single-Agent Pemetrexed for Chemonaïve and Pretreated Patients with Malignant Pleural Mesothelioma: Results of an International Expanded Access Program

Journal of thoracic oncology, 2008-07, Vol.3 (7), p.764-771

2008

Volltextzugriff (PDF)

A Randomized Phase II Trial of Pemetrexed plus Irinotecan (ALIRI) versus Leucovorin-Modulated 5-FU plus Irinotecan (FOLFIRI) in First-Line Treatment of Locally Advanced or Metastatic Colorectal Cancer

Oncology, 2007-01, Vol.73 (1-2), p.9-20

2007

Volltextzugriff (PDF)

Correlations of mRNA expression and in vitro chemosensitivity to enzastaurin in freshly explanted human tumor cells

Investigational new drugs, 2008-06, Vol.26 (3), p.215-222

2008

Volltextzugriff (PDF)

Gemcitabine in non-small cell lung cancer (NSCLC)

Investigational new drugs, 2000-02, Vol.18 (1), p.29-42

2000

Volltextzugriff (PDF)

PRS-03: Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S306-S306

2007

Volltextzugriff (PDF)

C5-01: Open-label study of pemetrexed alone or in combination with a platinum in chemonaïve patients (pts) with malignant pleural mesothelioma (MPM): Results from the International Expanded Access Program (EAP)

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S371-S371

2007

Volltextzugriff (PDF)

C5-03: Open-label study of pemetrexed alone or in combination with a platinum for previously treated patients (pts) with malignant pleural mesothelioma (MPM): Outcomes from the International Expanded Access Program (EAP)

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S372-S373

2007

Volltextzugriff (PDF)

Assessment of the value of confirming responses in clinical trials in oncology

European journal of cancer (1990), 2005-07, Vol.41 (11), p.1528-1532

2005

Volltextzugriff (PDF)

Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabine

European Journal of Nuclear Medicine, 2001-04, Vol.28 (4), p.418-425

2001

Volltextzugriff (PDF)

Assessment of the value of confirming responses in clinical trials in oncology. Commentary

European journal of cancer (1990), 2005, Vol.41 (11), p.1501-1502

2005

Volltextzugriff (PDF)

Preclinical evaluation of gemcitabine/paclitaxel-interactions in human bladder cancer lines

Anticancer research, 2003-11, Vol.23 (6C), p.4805

2003

Volltextzugriff (PDF)

PET 2-Fluoro-2-Deoxyglucose Uptake in Rat Prostate Adenocarcinoma During Chemotherapy with Gemcitabine

The Journal of nuclear medicine (1978), 1997-08, Vol.38 (8), p.1215-1221

1997

Volltextzugriff (PDF)

Fluorodeoxyglucose Uptake In Vitro: Aspects of Method and Effects of Treatment with Gemcitabine

The Journal of nuclear medicine (1978), 1994-11, Vol.35 (11), p.1842

1994

Volltextzugriff (PDF)

The efficacy of 2',2'-difluorodeoxycytidine (gemcitabine) and vinblastine combined with interferon in nude mice xenografts of human renal cell carcinoma

International journal of oncology, 1998-06, Vol.12 (6), p.1367

1998

Volltextzugriff (PDF)

The efficacy of 2',2'-difluorodeoxycytidine (gemcitabine) combined with interferon in human renal cell carcinoma cell lines

International journal of oncology, 1998-06, Vol.12 (6), p.1361

1998

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(34)
Bücher
(1)

Sprache

Englisch
(34)
Deutsch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies

Phase III Trial of Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care in Previously Treated Patients With Advanced Malignant Pleural Mesothelioma

Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial

Interaction of pemetrexed disodium (ALIMTA, multitargeted antifolate) and irradiation in vitro

Antifolate Pseudo-resistance Due to Elevated Levels of Thymidine and Hypoxanthine in a Commercial Serum Preparation

Radiosensitizing potential of gemcitabine (2′,2′-difluoro-2′-deoxycytidine) within the cell cycle in vitro

Pemetrexed Plus Cisplatin or Pemetrexed Plus Carboplatin for Chemonaïve Patients with Malignant Pleural Mesothelioma: Results of the International Expanded Access Program

Results of a Phase 3, Multicenter, Randomized, Placebo-Controlled Trial of Remimazolam: A New Ultra Short Acting Benzodiazepine for Bronchoscopy

Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B 12 as Front-Line Therapy in Malignant Pleural Mesothelioma

Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B12 as Front-Line Therapy in Malignant Pleural Mesothelioma

Single-Agent Pemetrexed for Chemonaïve and Pretreated Patients with Malignant Pleural Mesothelioma: Results of an International Expanded Access Program

A Randomized Phase II Trial of Pemetrexed plus Irinotecan (ALIRI) versus Leucovorin-Modulated 5-FU plus Irinotecan (FOLFIRI) in First-Line Treatment of Locally Advanced or Metastatic Colorectal Cancer

Correlations of mRNA expression and in vitro chemosensitivity to enzastaurin in freshly explanted human tumor cells

Gemcitabine in non-small cell lung cancer (NSCLC)

PRS-03: Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

C5-01: Open-label study of pemetrexed alone or in combination with a platinum in chemonaïve patients (pts) with malignant pleural mesothelioma (MPM): Results from the International Expanded Access Program (EAP)

C5-03: Open-label study of pemetrexed alone or in combination with a platinum for previously treated patients (pts) with malignant pleural mesothelioma (MPM): Outcomes from the International Expanded Access Program (EAP)

Assessment of the value of confirming responses in clinical trials in oncology

Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabine

Assessment of the value of confirming responses in clinical trials in oncology. Commentary

Preclinical evaluation of gemcitabine/paclitaxel-interactions in human bladder cancer lines

PET 2-Fluoro-2-Deoxyglucose Uptake in Rat Prostate Adenocarcinoma During Chemotherapy with Gemcitabine

Fluorodeoxyglucose Uptake In Vitro: Aspects of Method and Effects of Treatment with Gemcitabine

The efficacy of 2',2'-difluorodeoxycytidine (gemcitabine) and vinblastine combined with interferon in nude mice xenografts of human renal cell carcinoma

The efficacy of 2',2'-difluorodeoxycytidine (gemcitabine) combined with interferon in human renal cell carcinoma cell lines

Suchergebnisse filtern